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 1 
Abstract 2 
 3 
Background: Systemic hypertension (SH) is a potential complication of acute kidney injury 4 
(AKI) in dogs.  5 
Hypothesis/Objectives: To describe the prevalence of SH and hypertensive retinopathy in 6 
dogs with AKI, to investigate the relationship between SH and severity of AKI and to assess 7 
possible factors associated with SH. 8 
Animals: Fifty-two dogs with AKI. 9 
 10 
Methods: Prospective observational study of dogs presenting to a tertiary referral center that 11 
fulfilled the International Renal Interest Society (IRIS) guidelines for the diagnosis of AKI. 12 
Systolic blood pressure (SBP) measurement, urine protein/creatinine ratio (UPCR), urine 13 
output, presence of hypertensive retinopathy and fluid overload (FO), survival to discharge 14 
and length of hospitalization were subsequently assessed. The prevalence of SH was 15 
calculated and the relationship between SH and recorded factors was examined using non-16 
parametric statistics. 17 
 18 
Results: The prevalence of SH (≥160 mmHg) on admission or during hospitalization was 19 
75% (39/52) and in 56% (22/39) of cases this was severe (≥180 mmHg). Sixteen percent 20 
(7/43) of dogs had evidence of hypertensive retinopathy and 77% (24/31) dogs had UPCR 21 
>0.5. Forty-two percent (22/52) dogs had FO on admission or during hospitalization. There 22 
was no association between SH and IRIS AKI grade, oligo/anuria, survival to discharge, 23 
length of hospitalization or proteinuria. Dogs with FO on presentation were more likely to be 24 
hypertensive at admission compared to dogs without FO (p =0.024).  Dogs that did not 25 
survive to discharge were more likely to have FO (p =0.007).  26 
 27 
Conclusions and Clinical Importance:  SH is common in dogs with AKI. Systemic 28 
hypertension might be associated with FO, which itself is associated with non-survival. 29 
Monitoring for SH and FO is therefore warranted in dogs with AKI. 30 
 31 
Introduction 32 
 33 
Acute kidney injury (AKI) is defined as an acute and abrupt decrease in kidney function 34 
resulting in abnormal glomerular filtration rate, tubular function and urine production.1 35 
Systemic hypertension (SH) is a potential complication of renal injury with variable 36 
occurrence in both dogs and cats with chronic kidney disease (CKD) and AKI.2,3,4,5 37 
 38 
Systemic hypertension (SH) can lead to target organ damage which includes hypertensive 39 
retinopathy, hypertensive encephalopathy, left ventricular hypertrophy and progression of 40 
kidney disease. Hypertensive retinopathy occurs in both cats and dogs with CKD and 41 
hypertensive retinopathy and left ventricular hypertrophy occurs in dogs with glomerular 42 
disease secondary to leishmaniasis [Quatra M, Ippolito PD, Peruccico C, et al. Prevalence of 43 
ocular lesions in dogs with systemic hypertension and nephropathy/chronic renal failure: 82 44 
cases (2007-2010). In:Annual Scientific Meeting of the European College of Veterinary 45 
Ophthalmologists; May 10-13, 2018 E24].3,6,7 The cause or causes of SH in kidney disease 46 
have yet to be fully elucidated but theories include impaired excretion of sodium and 47 
subsequent volume overload, excessive activation of the renin-angiotensin-aldosterone 48 
system, stimulation of the sympathetic nervous system via activation of chemosensitive 49 
afferent fibres and increase in systemic vascular resistance secondary to endothelial 50 
dysfunction.8,9 51 
 52 
In dogs with CKD there is a  positive correlation between systolic blood pressure (SBP) and 53 
degree of proteinuria and both SH and proteinuria are associated with disease progression and 54 
reduced survival time.3,10 The prevalence of SH in CKD in various studies ranges between 9-55 
93%.11 Based on retrospective studies 81-87% of dogs with AKI have SH [Francey T, 56 
Cowgill LD. Hypertension in dogs with severe acute renal failure. J Vet Intern Med 57 
2004;18:418].4  The literature on the effect of SH on the outcome of animals with AKI is 58 
sparse. Glomerular filtration rate is significantly reduced in hypertensive dogs compared to 59 
non-hypertensive dogs.12  However, in AKI in cats presence of SH has no effect on survival.5 60 
 61 
The primary aims of this observational study were to describe the prevalence of SH and 62 
hypertensive retinopathy in dogs with AKI. The secondary aims were to investigate the 63 
relationship between SH and severity of AKI and to assess possible factors associated with 64 
SH. The hypotheses were that SH would be common in dogs with AKI, but ocular target 65 
organ damage (TOD) would be less frequently detected. We further hypothesized that there 66 
would be no association between SH, severity of AKI or survival to discharge. 67 
 68 
Materials and Methods 69 
 70 
The study was approved by by the Royal Veterinary College Clinical Research Ethical 71 
Review Board (URN 2016 1590). Dogs presenting to a university referral teaching hospital 72 
diagnosed with community acquired AKI were prospectively recruited between July 2016 73 
and November 2018.  Dogs were eligible for inclusion if they fulfilled the International Renal 74 
Interest Society (IRIS) guidelines for the diagnosis of AKI; known access to nephrotoxins, 75 
serum creatinine increase > 0.3mg/dL over a 48 hour period or serum creatinine >1.6mg/dL 76 
with one or more of the following criteria; evidence of renal tubular injury on urine analysis 77 
(renal glucosuria with normoglycemia, proteinuria with an inactive sediment and/or urinary 78 
casts), imaging findings suggestive of AKI or oliguria (urine output <1ml/kg/hr) over 6 79 
hours.13  80 
 81 
When available clinical records of the dogs were reviewed and dogs were excluded if there 82 
was any historical physical examination findings or previous clinicopathological data 83 
suggestive of CKD, including weight loss and/or polyuria and polydipsia greater than 4 84 
weeks in duration, and previously documented azotemia with urine specific gravity <1.030. 85 
All dogs had renal ultrasound performed and dogs were excluded if diagnostic imaging 86 
findings were indicative of CKD. These included; small irregular kidneys and the presence of 87 
renal infarcts. Dogs were also excluded if they failed to have an initial SBP or serum 88 
creatinine concentration measurement, had a co-existing disease associated with SH 89 
(including hyperadrenocorticism, diabetes mellitus, pheochromocytoma), were on medication 90 
which could result in SH (glucocorticoids, ciclosporin, toceranib), or if they had been treated 91 
with anti-hypertensive drugs such as angiotensin-converting enzyme inhibitors, angiotensin 92 
receptor blockers, beta blockers, calcium channel blockers or acepromazine in the 48 hours 93 
prior to enrolment. 94 
 95 
The grade of AKI was determined by the first serum creatinine concentration recorded from 96 
serum biochemistry (iLab 600®, Instrumentation Laboratory, Cheshire UK) when available, 97 
or bedside venous blood gas and metabolite sample (ABL90 FLEX, Radiometer UK Ltd, 98 
West Sussex UK). The underlying cause of AKI was determined based on clinician 99 
interpretation of history and clinicopathological data including haematology (ADVIA 100 
212Oi®, Siemens Healthcare, Surrey UK), serum biochemistry, microagglutination tests 101 
(Leptospirosis MAT®, IDEXX Laboratories, Horsham UK), infectious disease testing 102 
(SNAP® 4Dx®, IDEXX Laboratories, Horsham UK), diagnostic imaging, urinalysis, urine 103 
protein/creatinine (UPCR), urine culture and macroscopic and microscopic histopathological 104 
renal findings as appropriate. 105 
 106 
Systolic blood pressure (SBP) was measured within 12 hours of admission and at least once 107 
daily using Doppler sphygmomanometry. A standardized protocol adapted from the ACVIM 108 
consensus guidelines was used; the dog was allowed to acclimatize for 5-10 minutes before 109 
placement of a cuff (with cuff width being 30-40% of the circumference of the limb at the 110 
cuff site) on either the forelimb or hindlimb, at the discretion of the operator. The first 111 
measurement was discarded and a total of 5-7 consistent values were taken, discarding any 112 
SBP reading >20% than the other SBP measurements. The average of these readings was 113 
recorded.11 114 
 115 
Based on criteria in the ACVIM guidelines dogs were grouped based on their SBP and risk of 116 
TOD; normotensive (SBP<140mmHg), prehypertensive (SBP 140-159 mmHg), hypertensive 117 
(SBP 160-179 mmHg) and severely hypertensive (SBP ≥180 mmHg.11 Systemic hypertension 118 
was defined as a SBP≥ 160 mmHg. Where individual dogs had more than one series of blood 119 
pressure readings performed on a given day, a median daily SBP was used for analysis. Anti-120 
hypertensive therapy was at the discretion of the attending clinician. 121 
 122 
Fundic examination was performed once within 48 hours of admission by an American or 123 
European specialist in Ophthalmology or a supervised resident in training to assess for 124 
presence of hypertensive retinopathy.11 Pupil dilation was performed at the discretion of the 125 
ophthalmologist on a case-by-case basis. The ophthalmologists were unaware of the dog’s 126 
SBP.  127 
 128 
Urine output (UOP) was quantified either by measuring voided urine, weighing bedding or 129 
urethral catheterization. Oliguria was defined as a urine output less than 1ml/kg/hr for > 6 130 
hours.2 Fluid overload (FO) was diagnosed by the attending clinicians who determined this 131 
based on a daily dog assessment including monitoring for acute weight gain, serous nasal 132 
discharge, chemosis, subcutaneous edema or detection of cavitatory fluid with 133 
ultrasonography.14 Proteinuria was defined as UPCR > 0.5 with an inactive sediment.15 134 
Hypoalbuminemia was defined as serum albumin concentration <2.6g/dL. 135 
 136 
The IRIS grade of AKI, serum albumin concentration and UPCR on admission were 137 
recorded. SBP, UOP and evidence of FO were reviewed daily. Any change in AKI grade or 138 
SH classification during hospitalization was recorded, alongside the use of anti-hypertensive 139 
agents and any extracorporeal therapy. Hospitalization length, survival to discharge, survival 140 
at 3 months and follow up serum creatinine concentration and SBP where available were 141 
documented. The prevalence of SH and hypertensive retinopathy were calculated.   142 
 143 
Statistical analysis  144 
 145 
Data were assessed for normality using a Shapiro Wilks W test and a visual inspection of 146 
histograms. Normally distributed data were expressed as mean and standard deviation and 147 
non-normally distributed data expressed as median and ranges. Statistical analysis was 148 
performed using statistical software (SPSS Statistics, Version 22.0. IBM). 149 
 150 
Descriptive statistics were used to evaluate population characteristics.  A Fisher’s exact test 151 
was used to compare categorical data including number of dogs in each SBP category, AKI 152 
grade, presence of FO, proteinuria and hypoalbuminemia, and survival. A Bonferroni 153 
correction was used when comparing multiple categories. A Spearman's rank correlation 154 
coefficient was used assess for correlation between SBP, serum creatinine concentration and 155 
hospitalization length. The level of statistical significance was set at p < .05 and adjusted as 156 
needed when using the Bonferroni correction. 157 
 158 
Results 159 
 160 
Fifty-six dogs presented with AKI between July 2016-November 2018, of which 4 were 161 
excluded; 1 with prior history of anti-hypertensive therapy and 3 with incomplete data. Fifty-162 
two dogs were eligible for inclusion in the study. Of these dogs 49 were pure breeds; the 163 
most common pure breed was the Labrador (11/49) and 5/49 were sighthounds. Three out of 164 
fifty-two dogs were cross-breeds. Nineteen (37%) were male neutered, 18/52 (35%) female 165 
neutered, 7/52 (14%) female entire and 8/52 (15%) male entire. The median age and mean 166 
weight of dogs were 57 months (range 3-120) and 24.17kg+/-12.51 respectively.  Dogs 167 
presented with a variety of causes of AKI (Table 1).  Where a diagnosis was made, the most 168 
common were leptospirosis (12%, n=6), prior non-steroidal anti-inflammatory drug use 169 
(12%, n=6) and hypercalcemia (12%, n=6).  170 
 171 
 Table 1: Causes of acute kidney injury in fifty-two dogs presenting to a tertiary referral 
center 
Cause of AKI Number of dogs 
Leptospirosis 6 
NSAID use 
-NSAID and GA 
-NSAID and pyelonephritis 
-NSAID alone 
6 
3 
2 
1 
Hypercalcaemia 
-Hypercalcaemia 
-Hypercalcaemia and pyelonephritis 
6 
5 
1 
CRGV 4 
Ischemia 3 
Leishmania 2 
Ethylene glycol toxicity 2 
Grape and raisin toxicity 3 
Glomerulonephritis 2 
Unspecified toxin 1 
GA 1 
GA and rhabdomyolysis 1 
Rhabdomyolysis 1 
Diagnosis not made 14 
 
The median SBP on admission was 160 mmHg (range 50-275mmHg). The prevalence of SH 172 
(≥160 mmHg) on admission was 54% (28/52) and in 43% cases (12/28) this was severe 173 
(≥180 mmHg). The median peak SBP at any time point was 175 mmHg (range 90-174 
300mmHg). The prevalence of SH at some point during hospitalization was 75% (39/52) 175 
which was severe in 56% cases (22/39) (Table 2). Forty-three out of 52 dogs had a fundic 176 
examination during hospitalization and 21% (9/43) of these had evidence of ocular TOD. 177 
Two out of these 9 dogs, one in the normotensive category and the other in the pre-178 
hypertensive, did not have a hypertensive reading at any point during their hospitalization. 179 
Fundic examination findings included retinal hemorrhage (9/9), retinal vessel tortuosity (2/9), 180 
exudative retinal detachment -complete (1/9)/multifocal (1/9) and hyphema (3/9) (Figure 181 
1a,1b). Thirty-three percent (4/12) dogs that underwent a postmortem examination had 182 
evidence of left ventricular hypertrophy, 3 of 4 were hypertensive during hospitalization and 183 
one had retinal lesions.   184 
 185 
Twenty-five out of 39 (64%) dogs diagnosed with SH at some point during hospitalization 186 
were treated with anti-hypertensive drugs.  Those hypertensive dogs who did not receive anti-187 
hypertensive therapy had a short-lived hypertension (<48 hours) or died shortly after 188 
hypertension was diagnosed. Of the treated dogs 22/25 (88%) received amlodipine alone, 189 
1/25 (4%) received benazepril alone and 2/25 (8%) received multiple anti-hypertensive 190 
drugs. One dog received amlodipine, hydralazine and nitroprusside and the other received 191 
amlodipine, hydralazine and telmisartan. Both of these dogs had severe refractory 192 
hypertension (>200mmHg) and evidence of ocular TOD. The dogs given telmisartan and 193 
benazepril were categorized as AKI grade I and early grade III respectively. Choice of 194 
hypertensive therapy was based on the clinician’s discretion. The median daily dose of 195 
amlodipine was 0.19mg/kg (range 0.05-0.45mg/kg). This was given once a day in all dogs 196 
Abbreviations: AKI, acute kidney injury  CRGV, Cutaneous and renal glomerular 
vasculopathy GA, General anesthesia NSAIDS, non steroidals GA, General anesthesia 
CRGV, Cutaneous and renal glomerular vasculopathy  
 
 
Table 2: Prevalence of systemic hypertension at admission and during hospitalization in 
fifty-two dogs with acute kidney injury 
 
 Blood pressure category Prevalence 
Admission Normotensive 
(<140 mmHg) 
19.2% (10/52) 
Pre-hypertensive 
(140-159 mmHg) 
276.9% (14/52) 
Hypertensive  
(160 mmHg-179 mmHg) 
310.8% (16/52) 
Severe hypertension 
(≥180 mmHg) 
23.1% (12/52) 
During hospitalization Normotensive 
(<140 mmHg) 
109.6% (5/52) 
Pre-hypertensive 
(140-159 mmHg) 
15.4% (8/52) 
Hypertensive  
(160 mmHg-179 mmHg) 
323.7% (17/52) 
Severe hypertension 
(≥180 mmHg) 
42.3% (22/52) 


initially but was escalated to twice daily in one dog and given initially three times daily as 197 
incremental dose management in another in attempt to manage severe hypertension. Anti-198 
hypertensive therapy was associated with a reduction in hypertension category in 14/25 199 
(56%) of cases; 2/14 severe to normotensive, 7/14 severe to pre-hypertensive, 3/14 severe to 200 
hypertensive and 2/14 hypertensive to normotensive. Twelve of the 25 (48%) dogs given 201 
anti-hypertensive did not survive to discharge. Of the 13/25 (52%) dogs given anti-202 
hypertensive therapy that did survive to discharge 7/13 (54%) were discharged on therapy, 203 
4/13 (31%) had short lived hypertension in hospital and 2/13 (15%) were discharged to be 204 
euthanized.   205 
 206 
The median serum creatinine concentration on presentation was 5.53mg/dL (range 1.39- 207 
19.56mg/dL).  Five dogs out of the 52 (10%) had grade I AKI, 2/52 (4%) grade II, 17/52 208 
(33%) grade III, 17/52 (33%) grade IV and 11/52 (21%) grade V. Fourteen dogs (28%) had an 209 
increase in AKI grade during hospitalization.  There was no correlation between initial SBP 210 
and serum creatinine on presentation (rs= 0.182, p= 0.20). The prevalence of SH ranged 211 
between 50-91% across AKI grades (Table 3). There was no association between the presence 212 
of SH on admission or during hospitalization and IRIS AKI grade on presentation or increase 213 
in AKI grade during hospitalization.  214 
 215 
Twenty-nine out of 49 dogs were hypoalbuminemic (59%). The mean serum albumin 216 
concentration was 2.53g/dL +/- 0.54 (n=49). Thirty-four dogs had an UPCR measurement, of 217 
which 1/34 had gross hematuria and 2/34 had an active sediment and so these dogs were not 218 
included in further analysis. The median UPCR in the 31 remaining dogs was 1.68 (range 219 
0.1-18). Twenty-four out of thirty-one dogs (77%) had UPCR > 0.5 of which 14/24 (58%) 220 
  
Table 3: Prevalence of systemic hypertension and acute kidney injury grade on 
admission in fifty-two dogs with acute kidney injury 
 
IRIS AKI grade Prevalence of hypertension 
I 60.0% (3/5)  
II 50.0% (1/2) 
III 94.1% (16/17) 
IV 710.6% (12/17) 
V 910.9% (10/11) 
 
Abbreviations: AKI, acute kidney injury  IRIS, International Renal Interest Society AKI, 
acute kidney injury  
 
 
 
had a UPCR above 2. There was no association between presence elevated UPCR and 221 
hypoalbuminemia, or SH on admission or during hospitalization. 222 
 223 
A urethral catheter was placed in 54% (28/52) dogs. When considering all methods of urine 224 
measurement the median urine output was 1.4ml/kg/hr over the entire hospital period ranging 225 
from 0-25ml/kg/hr. Forty-two percent of dogs (22/52) were reported to be oliguric (urine 226 
output <1ml/kg/hr for > 6 hours), all of which received furosemide. Seven out of twenty dogs 227 
received a single bolus dose between 0.5-2mg/kg, 2/20 dogs had a bolus between 0.5-1mg/kg 228 
prior to a continuous infusion of 0.1-2mg/kg/hr and 11/20 had a continuous infusion between 229 
0.25- 0.8mg/kg/hr. In two dogs the bolus dose of furosemide was not recorded. There was no 230 
association between the presence of SH and the presence of oliguria or anuria (p= 0.22). Six 231 
dogs had extracorporeal therapy, 4/52 (78%) had continuous renal replacement therapy 232 
(CRRT) and 2/52 (4%) had total plasma exchange.  All four dogs that underwent CRRT were 233 
hypertensive on admission.  234 
 235 
Twelve dogs (23%) were considered to have FO on admission and 10/52 (19%) developed 236 
FO during hospitalization. Forty-two dogs (81%) received intravenous therapy prior to 237 
admission and 94% (49/52) received fluids at some point during hospitalization. In those 238 
dogs with FO on presentation, fluid therapy was administered after furosemide in 6/10 (60%), 239 
extracorporeal therapy in 2/10 (20%) and for replacement of varying insensible and sensible 240 
losses in 2/10 (20%) dogs. There was a significant association between FO on admission and 241 
SH on presentation (p= 0.024) but there was no association between SH and the development 242 
of FO in hospital. 243 
 244 
Twenty-five (48%) dogs survived to discharge and 3 dogs (6%) were discharged home for 245 
euthanasia. Of those dogs that did not survive to discharge 22/24 (92%) were euthanized and 246 
2/24 (8%) died. The mean length of hospitalization for the surviving dogs was 8.48 days +/- 247 
4.13. There was no correlation between the SBP and hospitalization length for dogs that 248 
survived (rs =0.225, p=0.28). There was no association between survival to discharge and SH 249 
on admission or during hospitalization, nor was there an association between IRIS AKI grade 250 
and survival. There was an association between the presence of FO at any point during 251 
hospitalization and survival to discharge (p =0.007).  252 
 253 
In those dogs that survived to discharge, 32.0% (8/25) were lost to follow up. Out of the 254 
remaining dogs 29% (5/17) died within 3 months.   Of the five dogs that died within 3 255 
months 2/5 were euthanized directly as a result of their AKI,  2/5 were euthanized as result of 256 
an underlying neoplastic process and 1/5 died of unrelated causes. Overall 3-month survival 257 
rate of all dogs available for follow up was 28% (12/44).  The presence of SH at admission 258 
and during hospitalization was not associated with three-month survival.  Five out of ten 259 
(50%) dogs that had serum creatinine measured within the 3 month follow up period after 260 
discharge had a serum creatinine above the upper limit of the laboratory defined value of  261 
>1.63mg/dL. All of these dogs were hypertensive at some point during hospitalization. Four 262 
out of five dogs who had blood pressure measurements between 2-12 week after discharge 263 
were found to be hypertensive and on therapy.  264 
 265 
Discussion 266 
 267 
This prospective study shows that the prevalence of SH is high in dogs with community 268 
acquired AKI and appears to increase during hospitalization; 54% of dogs were hypertensive 269 
on presentation and 43% had severe hypertension.  These values increased to 75% and 56% 270 
respectively during hospitalization. These results are similar to the currently reported SH 271 
occurrence rate of 81-87%  in dogs with AKI during hospitaliszation.4 [Francey T, & Cowgill 272 LD. Hypertension in dogs with severe acute renal failure. J Vet Intern Med. 273 2004;18:418].4 There is therefore a clear requirement for frequent blood pressure monitoring 274 
of animals hospitalised with AKI. 275 
 276 
Hypertensive retinopathy was detected in 16% dogs in this study. This is less than reported in 277 
a study of all causes of hypertension, which report a prevalence of 62%.16  However, the 278 
prevalence is similar to that previously described in dogs with CKD [Quatra M, Ippolito PD, 279 
Peruccico C, et al. Prevalence of ocular lesions in dogs with systemic hypertension and 280 
nephropathy/chronic renal failure: 82 cases (2007-2010). In: Annual Scientific Meeting of the 281 
European College of Veterinary Ophthalmologists; May 10-13, 2018 E24].3 The low 282 
prevalence of hypertensive retinopathy could be explained by the low number of dogs 283 
presenting with severe hypertension, the low rate of repeat ophthalmological examinations, or 284 
failure to detect early retinal lesions, as pupil dilation was not performed in all dogs. Two 285 
dogs, one in the normotensive category and one in the pre-hypertensive category, also had 286 
retinopathy consistent with hypertension. One of the dogs had AKI secondary to a 287 
combination of presumed renal hypotension secondary to general anesthesia and laparoscopy, 288 
and non-steroidal anti-inflammatory drug therapy. Retinal hemorrhage occurs in humans 289 
undergoing laparoscopic surgery suspected to be secondary to increased retinal venous 290 
pressure17 and therefore could explain this finding.  Alternatively, these findings could be 291 
explained by underestimation of the diagnosis of hypertension as a result of inherent 292 
inaccuracies of  indirect measures of SBP, or could suggest that macroscopic retinal vascular 293 
changes are not sensitive indicators of early ocular TOD. Studies of early stage untreated 294 
essential hypertension in humans failed to find a relationship between retinal microvascular 295 
changes and other validated markers of TOD such as 24-hour ambulatory blood pressure 296 
monitoring, 24-hour urine collection for microalbuminuria, echocardiography and carotid 297 
ultrasonography.18 Despite the seemingly low prevalence of hypertensive retinopathy in AKI, 298 
systemic heparinization in the presence of retinal hemorrhage could lead to severe retinal 299 
damage. An ophthalmological exam should therefore be considered in all AKI dogs prior to 300 
CRRT.  301 
 302 
There was no association between evidence of hypertensive retinopathy and severity of SH. 303 
This might be the result of a type II error due to the low numbers of dogs with evidence of 304 
hypertensive retinopathy or the temporal relationship between detection of SH and fundic 305 
examination. Fundic examination was standardized to occur in the first 48 hours and the 306 
number of severely hypertensive dogs at admission was low. Another factor shown to affect 307 
the development of TOD in people is the variability of SBP; greater variability of SBP has 308 
been shown to associated with greater risk of TOD.19 SBP variability was not assessed in this 309 
study but is something that should be considered in future studies.  310 
 311 
Left ventricular hypertrophy, indicative of cardiac TOD has been reported in 91% of 312 
hypertensive dogs with leishmaniasis, of which over half of the dogs had kidney disease.7 In 313 
our study 4/12 dogs that underwent a postmortem examination had evidence of left 314 
ventricular hypertrophy, of which three quarters of them were noted to be hypertensive 315 
during hospitalization and 1/4 had retinal changes.  These findings suggest a degree of 316 
chronicity of the SH and therefore might indicate a failure to diagnose chronic kidney disease 317 
in this subset of dogs. However, the possibility of the AKI occurring secondary to SH cannot 318 
be excluded. These results suggest other diagnostic tests such as echocardiography should be 319 
used alongside a fundic examination to further assess for TOD.  320 
 321 
Proteinuria has been associated with SH and persistent proteinuria is considered a finding 322 
indicative of TOD.11,20 Studies report a positive but non-linear correlation between SBP and 323 
UPCR in dogs.10,12,21 Proteinuria might also be the result of primary glomerular disease. A 324 
UPCR >2 alongside hypoalbuminemia is considered consistent with glomerulonephropathy15 325 
and SH has been shown to associated with glomerular disease in dogs.7 In our study over 326 
75% dogs had a UPCR > 0.5 of which 58% had UPCR >2. Few previous studies have 327 
quantitatively assessed proteinuria in AKI dogs; 78% dogs with leptospirosis were reported 328 
to have an elevated UPCR22 and in another study of 125 dogs UPCR values between 0.09-72 329 
were reported in dogs with AKI of all causes and the degree of proteinuria was significantly 330 
greater in non-survivors.23 In the current study there was no association between proteinuria 331 
and hypoalbuminemia, SH and survival to discharge. Failure to detect an association between 332 
SH and proteinuria might be the result of a type II error due to the small number of dogs with 333 
UPCR measurement or secondary to the effect of treatment; hypertensive dogs were treated 334 
at the clinician’s discretion and many had improvement in their SBP category which could 335 
have masked an association between SH and proteinuria. Alternatively, the proteinuria could 336 
have been predominantly tubular in origin rather than a result of glomerular hypertension. 337 
Future studies with renal biomarkers of glomerular and tubular injury such as fractional 338 
excretion of IgG and IgM and urine neutrophil gelatinase-associated lipocalin (NGAL) 339 
alongside trending of UPCR in dogs with AKI over time might help determine the origin of 340 
this proteinuria and could have significant consequences of the choice of anti-hypertensive 341 
therapy.  342 
 343 
There was no association between the presence of SH and IRIS AKI grade or absolute serum 344 
creatinine concentration. This is similar to findings in cats with AKI and in dogs with 345 
cardiorenal syndrome.5,24 These finding suggests SH can occur at all grades of AKI. 346 
Interestingly, canine studies have shown a reduction in glomerular filtration rate (GFR) 347 
correlates with an increase in SBP.10,12 In an experimental canine study, hypertensive dogs 348 
had a significantly reduced GFR and increase in renal tubular lesions and fibrosis compared 349 
to normotensive dogs in the weeks to months after AKI, suggesting SH has appreciable 350 
adverse effect on kidney structure and function.12  In the current study SH was treated at the 351 
clinician’s discretion and hypertensive category reduced in around half of the dogs. This 352 
intervention could have masked the potential effect of SH on disease progression and 353 
outcome. Furthermore, the number of cases loss to follow up was high and follow up 354 
sampling was not standardized reducing the study’s power to detect the long-term effect of 355 
SH on kidney function. Finally, the IRIS guidelines used in this study for grading AKI are 356 
based on serum creatinine concentrations alone which is not considered an accurate indicator 357 
of GFR.13, 25 Future studies should therefore consider the routine use of commercial measures 358 
of GFR at standardized follow up time points.  359 
 360 
There was no association between SH at admission or development during hospitalization 361 
and survival nor between AKI grade and survival to discharge. The failure to detect an 362 
association between SH and survival to discharge is similar to that reported in cats with 363 
AKI.5   Dogs enrolled had no pre-treatment with anti-hypertensive agents and therefore we 364 
can reliably assess the effect of previously untreated SH on admission with disease severity 365 
and outcome. However, during hospitalization anti-hypertensive therapy was administered at 366 
the clinician’s discretion and in around half of treated dogs their hypertension resolved. It is 367 
therefore difficult to elucidate the effect of persistent hypertension on outcome in this study. 368 
It is plausible that anti-hypertensive therapy masked the effect of SH on survival. The lack of 369 
association between severity of AKI and outcome is surprising and contrary to previous 370 
studies of AKI whereby increased AKI grade was associated with worsened outcome.23, 26, 27 371 
This difference could be explained by differences in causes of AKI in our population versus 372 
others and the over-reaching effect of etiology on outcome in AKI irrespective of absolute 373 
serum creatinine concentration. The study’s small size, particularly the number of dogs in 374 
lower AKI grades, might also contribute to failure to detect an effect of AKI grade and 375 
outcome.  376 
 377 
Of those dogs which survived and for which information was available, 50% were azotemic 378 
on one or more occasion after discharge.  All of these dogs were hypertensive at some point 379 
during hospitalization. Inferences on the effect of SH on development of CKD cannot be 380 
made given the small number of dogs, but this supports the need for regular monitoring of 381 
dogs after an episode of AKI. Only five dogs had follow-up blood pressure, of which 4/5 382 
were persistently hypertensive and on anti-hypertensive therapy. Monitoring blood pressure 383 
after discharge is particularly important considering human AKI dogs are more likely to 384 
develop hypertension during follow up.28 385 
 386 
Despite the frequent occurrence of SH in dogs with kidney disease the pathogenesis is poorly 387 
understood. Suggested etiologies include volume impaired excretion of sodium leading to 388 
volume overload, excessive activation of the renin angiotensin-aldosterone system, 389 
stimulation of the sympathetic nervous system secondary to activation of chemosensitive 390 
afferent neurons by local ischemia and inflammation, reduced bioavailability of the 391 
vasodilator nitric oxide and increased production of the vasoconstrictor endothelin. 8,9 In this 392 
study the presence of SH at admission was associated with the presence of FO at admission 393 
suggesting a role for volume and sodium excess in the pathogenesis of hypertension in this 394 
population. It is unclear why this relationship did not persist during hospitalization but the 395 
authors hypothesize it is related to the duration of FO; during hospitalization daily frequent 396 
monitoring of weight encourages early detection of FO. This might prompt the de-escalation 397 
of fluid therapy prior to the development of clinically detectable volume overload. In human 398 
dialysis, dogs’ volume status, particularly those with FO are associated with both pre-dialysis 399 
and post-dialysis blood pressure.  Blood pressure falls during hemodialysis with fluid 400 
removal and the decrease in blood pressure is greatest with larger amounts of fluid removal 401 
and with higher ultrafiltration rates.29 In the current study, four dogs underwent continuous 402 
renal replacement therapy as part of their management, all of which were hypertensive. SH 403 
did not resolve after therapy in any of the dogs, despite resolving their FO, suggesting this 404 
might only partly contribute to SH in AKI.  Further studies of volume status in dogs with 405 
AKI and SH, using standardized measures of volume status such as bioimpedance are 406 
required. In this study the presence of FO at any point during hospitalization was also 407 
associated with a reduced survival to discharge and this is consistent with studies in critical 408 
dogs and people undergoing renal replacement therapy.30, 31 This finding highlights the need 409 
for careful monitoring and judicious fluid therapy dogs with AKI. 410 
 411 
Amlodipine at a daily dose range of 0.1-1.2mg/kg was the predominant therapy for 412 
hypertension used in this study. One dog received a dose above the recommended range of 413 
0.1- 0.5mg/kg PO11 similar to a previous study where doses up to 1mg/kg were required.4 414 
Despite treatment, the hypertensive category only reduced in around half of the treated dogs. 415 Failure to achieve control is likely due to failing to appropriately adjust anti-416 hypertensive medication in light of persistent hypertension, particularly in those dogs 417 who had shorter survival times. Additional contributing factors include; the potential 418 
for reduced oral bioavailability of amlodipine in critically ill dogs32 and secondary 419 
glomerular hypertension as a consequence of preferential afferent arteriole vasodilation with 420 
amlodipine therapy.11 Further studies assessing amlodipine levels, proteinuria, and continuous 421 
blood pressure measurements in critical AKI dogs are required to best determine the dose and 422 
role of the drug in these dogs. 423 
 424 
This study had several limitations. It was conducted in a referral center and therefore the 425 
availability of complete medical records prior to referral was variable and the majority of 426 
dogs received treatment, including fluid therapy, prior to referral. The diagnosis of FO 427 
involved subjective assessment and was therefore less accurate than determining fluid 428 
balance based on calculations of fluid in and fluids out and the use of bioimpedance 429 
techniques.  430 
 431 
AKI grade was determined based on the first recorded serum creatinine concentration and 432 
therefore the method of measurement was not standardized. This could lead to inter-433 
individual variation in serum creatinine concentration and could affect subsequent AKI 434 
grading. Furthermore, only seven dogs with IRIS AKI grade I and II were enrolled reducing 435 
the distribution of data. Being a clinical study there was no pre-defined guidelines for 436 
management of SH, nor was there a control un-treated group of dogs. This, therefore, limits 437 
the study’s power to determine the effect of SH on AKI severity and outcome.  Furthermore, 438 
there was no standardization of management of dogs once discharged and there was a high 439 
occurrence of loss to follow up of dogs that survived to discharge. This, thereby limits the 440 
assessment of the effect of SH on longterm kidney function. Further studies should focus on 441 
the efficacy of pre-defined anti-hypertensive therapy and routine follow up including serum 442 
creatinine and other biomarkers of kidney function, urinalysis and GFR measurements to 443 
fully assess the effect of SH and development of CKD.  444 
 445 
Situational hypertension, an increase in blood pressure as a result of adrenergic stimulation 446 
during situations of stress or anxiety, is difficult to control in any clinical study.11 Situational 447 
hypertension has been documented in hospitalized dogs, in particular greyhounds. 31,33, 34 448 
Furthermore, greyhounds have significantly higher SBP than other breeds.35 In this study 449 
there were 5 sighthounds and 3/5 were considered hypertensive, of which two had SBP over 450 
180 mmHg.  Although in the majority of studies the increase in blood pressure in the hospital 451 
was marginal, values up to 200 mmHg are reported and therefore the presence of situational 452 
hypertension could lead to misclassification of dogs in all hypertensive categories. 35,36 453 
Despite hospital protocols being in place to minimise the effect of stress on the blood 454 
pressure readings and following ACVIM guidelines11 to measure blood pressure, the 455 
prevalence of SH in this study might have been increased by dogs with solely situational 456 
hypertension.  Continuous blood pressure monitoring would be required to fully mediate the 457 
effect of situational hypertension.  458 
 459 
Doppler sphygmomanometery is a recognised indirect measure of blood pressure. However, 460 
indirect blood pressure measurements have been shown to underestimate SBP in the 461 
hypertensive dog and therefore using this methodology might have underestimated the true 462 
prevalence of SH.37 The gold standard technique for measurement of blood pressure is direct 463 
arterial catheterization, but is not practical in this subset of dogs. Telemetric blood pressure 464 
measurement could be useful both during hospitalization and after discharge to reliably detect 465 
SH, TOD and the effect of treatment in dogs with AKI.38  466 
 467 
In summary, SH is common in dogs with AKI. However, hypertensive retinopathy appears to 468 
be uncommon. Systemic hypertension can occur at all grades of AKI and therefore SBP 469 
should be monitored in all dogs with AKI irrespective of severity.  Systemic hypertension on 470 
admission does not appear to affect outcome, however, in light of the routine use of anti-471 
hypertensives the effect of persistent SH on outcome cannot be fully elucidated from this 472 
study. The relationship between FO and SH needs to be further explored but considering FO 473 
was associated with worsened outcome measures should be taken to monitor for, and prevent 474 
FO in dogs with AKI. 475 
 476 
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